Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,767 | 1,872 | 7 | -372 | -105 |
| Other Working Capital | 1,303 | 842 | 400 | 102 | -570 |
| Other Operating Activity | -7,808 | -3,771 | -1,099 | 64 | -3 |
| Operating Cash Flow | $-1,738 | $-1,057 | $-692 | $-206 | $-678 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 60 | 0 | 0 | 0 | -250,000 |
| Investing Cash Flow | $60 | $0 | $0 | $0 | $-250,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 544 | 0 | 0 | 0 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 252,013 |
| Financing Cash Flow | $544 | $0 | $0 | $0 | $252,013 |
| Beginning Cash Position | 1,335 | 1,335 | 1,335 | 1,335 | 0 |
| End Cash Position | 201 | 278 | 643 | 1,129 | 1,335 |
| Net Cash Flow | $-1,134 | $-1,057 | $-692 | $-206 | $1,335 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,738 | -1,057 | -692 | -206 | -678 |
| Free Cash Flow | -1,738 | -1,057 | -692 | -206 | -678 |